Source: The Business Journals

Enzyvant: Biotech to expand Triangle footprint with $34M manufacturing site in Morrisville

A biotech with research and development offices in Durham is building a new facility in Morrisville to manufacture its drug that was recently approved by the FDA.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Rachelle Jacques's photo - CEO of Enzyvant

CEO

Rachelle Jacques

CEO Approval Rating

90/100

Read more